Other research discovered that the autophagy inhibitor 3-MA significantly promotes IL-24-induced apoptosis in oral squamous cell carcinomas (OSCC), suggesting that combining 3-MA and IL-24 may be a potential method in immunotherapy. The gene discussed is IL24; the disease is oral cavity squamous cell carcinoma.